A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery
Completed · Phase 1
Conditions studied: Single Ventricle Cardiac Anomaly
In brief
An initial feasibility and safety study evaluating the use of autologous tissue engineered vascular grafts as extra cardiac total cavopulmonary connection (EC TCPC) conduits in children with single ventricle anomalies.
Key facts
- Study ID
- NCT01034007
- Run by
- Christopher Breuer
- People needed
- 4
- Starts
- 2009-12-01
- Expected to finish
- 2018-01-23
- Last updated by the study team
- 2018-03-02
Who can join
Age: 1 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- single ventricle cardiac anomaly requiring extra cardiac total cavopulmonary connection (EC TCPC).
You may not qualify if…
- incomplete inferior vena cava (IVC)
Where it is running
- Nationwide Children's Hospital — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.